What are telomeres — and why should I care?

Telomeres are repeating sequences of DNA (the same six letters — TTAGGG — over and over) that sit at the ends of every chromosome. They function like the plastic tips on shoelaces: they keep the chromosome from fraying or fusing with other chromosomes. Every time a cell divides, the telomeres get a tiny bit shorter. When they get too short, the cell can no longer divide. Telomere length is now widely used as a biomarker of biological age — and yes, your telomeres really are getting shorter as you read this. The Nobel Prize was awarded for understanding this system, so it is genuinely foundational to how we think about aging at the cellular level.

Is Epitalon the same as Epithalon?

Yes — Epitalon and Epithalon are the same compound. The spelling difference comes from transliteration of the original Russian name. Some researchers also use AEDG, which is just the four amino acids in single-letter code. All three names appear in published literature. This library uses Epitalon — the spelling Khavinson originally used and the spelling indexed in PubMed.

Does Epitalon really exist naturally in the body?

Yes — which is unusual for a research peptide. It was confirmed in 2017, when researchers detected Epitalon in physiological pineal gland extract for the first time. Before then it was assumed to be entirely synthetic. The body produces small amounts naturally, and research suggests these levels decline with age along with overall pineal gland function.

Does the cell-line study establish cancer safety?

No. The 2025 study concerns particular cell lines and cannot establish long-term cancer risk or safety in people. The publisher replaced Figures 1, 2 and 3 in a November 2025 correction. Read the corrected figures; neither cell-line findings nor a difference between telomerase and ALT activity constitutes clinical safety evidence.

How does Epitalon relate to Pinealon?

Both are Khavinson bioregulator peptides from the same Russian research programme. Both are tiny — Epitalon is 4 amino acids (AEDG), Pinealon is 3 amino acids (EDR). They target different tissues. Epitalon is from the pineal gland and primarily targets telomerase. Pinealon targets brain and central nervous system tissue for neuroprotection research. Same theoretical framework — small peptides interacting with DNA to regulate gene expression — applied to different systems.

Research Library›Bioregulators & Neuropeptides›Epitalon

Telomerase Activator

Epitalon: The Complete Guide

A four-amino-acid peptide derived from the pineal gland — one of the most-studied compounds in aging research, with a published research history stretching back more than 25 years.

8 min read·6 studies cited·Updated April 2026

Evidence level

Preclinical only — animal and cell studies

Human data in the programme largely concerns the precursor extract

What this level means

Quick Reference

Also Known As	Epithalon, Epithalone, AEDG
Sequence	Ala-Glu-Asp-Gly (just 4 amino acids)
Target	Telomerase enzyme (hTERT)
Source	Originally extracted from pineal gland
Storage	Refrigerate (2–8°C)

What is Epitalon?

Epitalon is one of the smallest peptides in the entire research library — just four amino acids (Alanine, Glutamic acid, Aspartic acid, Glycine — which is why you sometimes see it written as AEDG). It also goes by the spelling Epithalon in some literature, but the canonical name comes from Russian researcher Vladimir Khavinson, whose lab at the St. Petersburg Institute of Bioregulation and Gerontology has been investigating it for over four decades.

Here is the part most people do not know: in 2017, researchers confirmed that Epitalon is not just a synthetic compound — it actually exists naturally in human pineal gland tissue. The pineal gland is a tiny structure deep in the brain (about the size of a grain of rice), most famous for producing melatonin and regulating sleep. Epitalon was originally identified as a fragment of a larger pineal extract called Epithalamin. The research synthetic version is a copy of that natural fragment.

What makes Epitalon interesting in longevity research is one specific thing: it appears to switch on telomerase, an enzyme most adult cells normally keep turned off. To understand why that matters, picture telomeres — the protective caps on the ends of your chromosomes. Researchers describe them as "the plastic tips on shoelaces" because that is exactly what they do. They keep the chromosome from fraying. Every time a cell divides, those tips get a tiny bit shorter. When they get too short, the cell stops dividing. The 2009 Nobel Prize in Physiology or Medicine was awarded for working out how this telomere system works in the first place — that is how foundational it is to understanding aging at the cellular level.

Research Applications

Research on Epitalon spans more than 25 years and a remarkable body of published work. The Khavinson programme alone produced 775 publications and 196 patents on bioregulator peptides — Epitalon is widely considered the centrepiece. Here is where the published research has focused:

🧬

Telomerase Reactivation

In most adult cells, the gene that produces telomerase (called hTERT) is switched off — which is why telomeres get shorter as we age. Research suggests Epitalon turns this gene back on. When telomerase is active, it adds protective sequence back onto the ends of chromosomes. This is the central finding that put Epitalon on the longevity research map.

🌙

Pineal-Melatonin Connection

Because Epitalon comes from the pineal gland — the brain region that produces melatonin — much of the research has examined whether Epitalon influences melatonin production in aging models. As we age, the pineal gland naturally produces less melatonin. Research suggests Epitalon may help support pineal function in research settings.

⏳

Lifespan Studies in Animals

Some of the most-cited Epitalon findings come from long-term animal studies, where research suggests treated animals lived 20–40% longer than untreated controls and showed slowed age-related changes across multiple biomarkers. These are decades-old findings, replicated across multiple Khavinson programme studies.

📚

The Khavinson Bioregulator Programme

Epitalon is the flagship of a much larger research programme led by Professor Vladimir Khavinson over more than 40 years. The programme produced hundreds of bioregulator peptides — small peptides designed to act on specific tissues. Epitalon has the strongest dataset of the family.

🕐

Circadian Rhythm Research

Beyond melatonin, research has examined whether Epitalon influences the broader circadian rhythm — the internal 24-hour clock that controls sleep, hormone release, and cellular repair cycles. Disrupted circadian rhythm is an active research area in aging biology.

💊

Small Enough to Reach DNA

Most peptides are too large to enter cell nuclei — they work on cell surfaces instead. Research suggests Epitalon, at just 4 amino acids, is small enough to enter the nucleus and interact with DNA directly, influencing which genes are switched on or off. This is the proposed mechanism for how it might reactivate telomerase.

How Epitalon Works

The big-picture answer first: research suggests Epitalon works by entering cells, reaching the nucleus where DNA lives, and switching on a gene that most adult cells keep switched off. That gene produces an enzyme called telomerase. When telomerase is active, it rebuilds telomeres — the protective caps on chromosomes that get shorter every time a cell divides.

Telomerase, in plain language: imagine telomeres as the plastic tips on shoelaces, and telomerase as the machine that rebuilds the plastic tips. In most adult cells, that machine is unplugged. Stem cells and reproductive cells keep it running, which is why those cells can divide indefinitely. Most other cells have a built-in division limit — the Hayflick limit — because the telomeres get shorter and shorter until division becomes impossible. Research suggests Epitalon plugs the machine back in, at least partially, in cells where it has been switched off.

How a four-amino-acid peptide influences gene expression: molecular modelling studies suggest Epitalon binds preferentially to specific histone proteins (the spool-like proteins that DNA wraps around). When Epitalon binds, it appears to change how tightly the DNA is wound at certain points — making certain genes more accessible for transcription. This is an epigenetic mechanism: it does not change the DNA sequence itself, but it changes which genes are expressed. The same mechanism may explain why Epitalon shows effects beyond telomerase alone.

Tissue specificity: not every peptide works on every tissue. Confocal microscopy studies suggest Epitalon selectively protects aged human pineal cells from age-related changes in research models, while showing no comparable effect on, for example, thymus cells. Research suggests this tissue specificity is consistent with the broader Khavinson bioregulator theory — that short peptides carry tissue-specific regulatory signals encoded in their amino acid sequence.

The melatonin link: through its action on pineal gland cells, research suggests Epitalon influences melatonin production. Since melatonin regulates circadian rhythm, immune function, and acts as a powerful antioxidant, this single pathway may contribute to the broader effects observed in long-term animal studies.

Storage Guidelines

Store at 2–8°C in a cool, dry place. Protect from light and moisture. Refrigerate once in solution form.

Frequently Asked Questions

Technical Specifications

Full Name	Epitalon (Epithalon, Epithalone)
Sequence	Ala-Glu-Asp-Gly (AEDG)
Amino Acid Count	4 (tetrapeptide)
Molecular Formula	C₁₄H₂₂N₄O₉
Molecular Weight	390.35 g/mol
Appearance	White to off-white lyophilised powder
Solubility	Freely soluble in water
Storage (Powder)	2–8°C refrigerated, −20°C long-term
Storage (Solution)	2–8°C, do not freeze
Origin	Khavinson bioregulator / pineal gland
Naturally Occurring	Yes (confirmed in pineal extract, 2017)

Compiled by the Southern Pacific Labs research team. Last updated April 2026.

Browse the research range →

Published References

Ullah S, Haider Z, Perera CD, et al. “Epitalon-activated telomerase enhance bovine oocyte maturation rate and post-thawed embryo development.” Life sciences, 2025. PubMed
A 2025 bovine oocyte and embryo laboratory study from a separate research group. Reported maturation and post-thaw embryo outcomes concern a livestock model, not human fertility, longevity or cancer safety.
Khavinson VKh, Bondarev IE, Butyugov AA. “Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells.” Bulletin of experimental biology and medicine, 2003. PubMed
The original study showing Epitalon switches on telomerase and lengthens telomeres in human cells. The foundational paper for everything that followed — this is the one that put Epitalon on the longevity research map.
Al-Dulaimi S, Thomas R, Matta S, et al. “Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity.” Biogerontology, 2025. PubMed
A cell-line study with corrected figures. Its findings do not establish cancer safety or clinical benefit.
The publisher replaced Figures 1, 2 and 3 in a correction published in November 2025. Interpret the cell-line findings using the corrected figures; they are not clinical efficacy evidence. View notice
Araj SK, Brzezik J, Mądra-Gackowska K, et al. “Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties.” International journal of molecular sciences, 2025. PubMed
A 2025 review summarising the current state of Epitalon research — useful as a starting point if you want to understand the field as it stands today rather than where it was 20 years ago.
Khavinson VK, Pendina AA, Efimova OA, et al. “Effect of Peptide AEDG on Telomere Length and Mitotic Index of PHA-Stimulated Human Blood Lymphocytes.” Bulletin of experimental biology and medicine, 2019. PubMed
A more recent Khavinson study looking at Epitalon's effect on white blood cells — specifically how often the cells divided and how long their telomeres were after treatment.
Anisimov VN, Khavinson VKh. “Peptide bioregulation of aging: results and prospects.” Biogerontology, 2010. PubMed
A broader review of the entire Khavinson bioregulator programme — useful context for understanding where Epitalon sits in the larger family of short-peptide aging research compounds.

Browse all Epitalon research on PubMed →